TherapeuticsMD (TXMD) Gross Profit Growth (3y) (2014 - 2023)
TherapeuticsMD (TXMD) Gross Profit Growth (3y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 6.23% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.42% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -0.01% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 8.70% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.26% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 28.48% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.60% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -69.09% |
| Sep 30, 2023 | -26.06% |
| Jun 30, 2023 | -58.91% |
| Mar 31, 2023 | -64.80% |
| Dec 31, 2022 | 73.97% |
| Mar 31, 2022 | 65.65% |
| Dec 31, 2021 | 49.90% |
| Sep 30, 2021 | 93.56% |
| Jun 30, 2021 | 78.66% |
| Mar 31, 2021 | 69.10% |
| Dec 31, 2020 | 68.86% |
| Sep 30, 2020 | 62.88% |
| Jun 30, 2020 | 20.87% |
| Mar 31, 2020 | 42.06% |
| Dec 31, 2019 | 51.06% |
| Sep 30, 2019 | 73.05% |
| Jun 30, 2019 | 13.85% |
| Mar 31, 2019 | -5.91% |
| Dec 31, 2018 | -1.98% |
| Sep 30, 2018 | -11.45% |